相关实验视频

Updated: Sep 19, 2025

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

缺少PD-1受体可以增强CD30⁺ T_reg细胞在黑色素瘤中的功能

Jing Xuan Lim^1,2,3, Tegan McTaggart^1,2,3, Seol Kyoung Jung⁴

¹Biosciences Institute, Newcastle University, Newcastle University, Newcastle upon Tyne, UK.

Nature immunology

|June 2, 2025

概括

编程细胞死亡1受体 (PD-1) 缺陷通过CD30促进调节性T (Treg) 细胞免疫抑制. 这一发现揭示了PD-1作为一个限制Treg细胞功能的检查点,可能改善癌症疗法.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
细胞信号传输细胞信号传输

背景情况:

调节性T (Treg) 细胞对于维持免疫平衡和通过免疫抑制预防自身免疫性至关重要.
在Treg细胞活动中,编程细胞死亡1受体 (PD-1) 的功能是复杂的和有争议的,特别是在瘤微环境中.

研究的目的:

调查PD-1在调节Treg细胞功能和抑制能力方面的精确作用.
阐明PD-1影响Treg细胞活动的分子机制,特别是在癌症的背景下.

主要方法:

在缺乏PD-1的小鼠中分析Treg细胞功能.
在Treg细胞中评估共抑制受体表达,STAT5信号通路和CD30表达.
评估瘤微环境中的Treg细胞抑制活性.

主要成果:

缺少PD-1导致增强的Treg细胞抑制功能.
这种增强是由共抑制受体的补偿网络介导的,CD30发挥着关键作用.
从机制上讲,PD-1 缺乏会提高STAT5信号的调节,这反过来又会增加Treg细胞上CD30的表达.

结论:

PD-1作为Treg细胞中CD30表达的负调节器或检查点,从而限制其抑制潜力.
这些发现表明,针对Treg细胞中的PD-1/CD30轴可能是增强抗瘤免疫力的可行策略.
了解PD-1对Treg细胞的影响,为开发用于癌症治疗的新型组合免疫疗法开辟了道路.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...